SAMSUNG PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 001360 for the last quarter is 12.17 B KRW, and it's 1.24% higher compared to the previous quarter. The net income of Q1 24 is -4.81 B KRW.